Contrastingly, Kim et al. found that Notch signaling downregulated p53 activation in human colon cancer owing to the inhibition of phosphorylation, further preventing the promoter binding ability of p53, and thereby increasing responsive cell growth [49]. The gene discussed is TP53; the disease is colonic neoplasm.